Union européenne - espagnol - EMA (European Medicines Agency)

alexion europe sas - ravulizumab - hemoglobinuria, paroxística - inmunosupresores selectivos - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

Argentine - espagnol - SANI (Asociación de Cooperativas Argentinas)

generar laboratorio veterinario - imidacloprid (1); permetrina (2); butoxido de piperonilo; agentes de formulacion c.s.p.; 1) 1-(6-cloro-3-piridinil) metil – 45-dihidro-n-nitro-1h-imidazol –2 -amina; 2) 22 – dimetil-3-(22-diclorovinil – ciclopropil – 1 – carboxilato de 3- penoxibencilo. - imidacloprid (1) 7,60 g.; permetrina (2) 35,70 g; butoxido de piperonilo 1 g.; agentes de formulacion c.s.p. 100 ml.; 1) 1-(6-cloro-3-piridinil) metil – 45-dihidro-n-nitro-1h-imidazol –2 -amina ; 2) 22 – dimetil-3-(22-diclorovinil – ciclopropil – 1 – carboxilato de 3- penoxibencilo. - caninos

Argentine - espagnol - SANI (Asociación de Cooperativas Argentinas)

laboratorios konig s. a. - imidacloprid 1-(2 cloro-5-piridimetil)-2-(nitroimino)imidazolidina); fenoxicarb (2-4-fenoxifenoxi)etilcarbamato de etilo; excipientes c.s.p. - imidacloprid 1-(2 cloro-5-piridimetil)-2-(nitroimino)imidazolidina) 8 g; fenoxicarb (2-4-fenoxifenoxi)etilcarbamato de etilo 0,5 g; excipientes c.s.p. 100 ml. - felinos

Argentine - espagnol - SANI (Asociación de Cooperativas Argentinas)

laboratorios konig s. a. - permetrina (22-dimetil-3(22-diclorovinil)-ciclopropil-1-carboxilato de 3 fenoxibencilo); imidacloprid (1-(2 cloro-5-piridimetil)-2-(nitroimino)imidazolidina); excipientes c.s.p.. - permetrina (22-dimetil-3(22-diclorovinil)-ciclopropil-1-carboxilato de 3 fenoxibencilo) 45 g; imidacloprid (1-(2 cloro-5-piridimetil)-2-(nitroimino)imidazolidina) 10 g; excipientes c.s.p.. 100 ml - caninos

Argentine - espagnol - SANI (Asociación de Cooperativas Argentinas)

elanco animal health - cada ml contiene; acido 1-(n-butilamino)-1 metiletil-fosfónico 100 mg; vitamina b 12 0.05 mg; excipientes c.s.p. 1 ml - cada ml contiene ; acido 1-(n-butilamino)-1 metiletil-fosfónico 100 mg ; vitamina b 12 0.05 mg ; excipientes c.s.p. 1 ml - bovinos; caninos; caprinos; equinos; felinos; ovinos; porcinos

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bexal farmaceutica s.a. - alfuzosina hidrocloruro - comprimido de liberaciÓn prolongada - 10 mg - alfuzosina hidrocloruro 10 mg - alfuzosina

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - rabeprazol sodico - comprimido gastrorresistente - 10 mg - rabeprazol sodico 10 mg - rabeprazol

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - rabeprazol sodico - comprimido gastrorresistente - 20 mg - rabeprazol sodico 20 mg - rabeprazol

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

accord healthcare, s.l.u - glimepirida - excipientes: carboximetilalmidon sodico,lactosa monohidrato - fÁrmacos hipoglucemiantes excluyendo insulinas - derivados de las sulfonilureas - glimepirida

Espagne - espagnol - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

merck sharp & dohme animal health, s.l. - virus herpes equino tipo 4 (2252), virus herpes equino tipo 1- ( rac-h), virus influenza equina inactivado, a/equi 1/praga/1/56 (h7n7), virus influenza equina inactivado, a/equi 2/newmarket/1/93 (h3n8), virus influenza equina inactivado a/equi 2/newmarket/2/93 (h3n8) - suspensiÓn inyectable - excipientes: timerfonato sodico, hidroxido de aluminio, neomicina, formaldehido, pbs, inmunostim - virus de la influenza equina + virus de la rinoneumonitis equina - caballos